Nagasaki schizophrenia study: Influence of the duration of untreated psychosis on long-term outcome

Acta Medica Nagasakiensia

Volumn 50, Issue 1, 2005, Pages 17-22

  Kinoshita, Hirohisa ^a   Nakane, Yoshibumi ^b   Nakane, Hideyuki ^a   Ishizaki, Yuka ^a   Honda, Sumihisa ^a   Ohta, Yasuyuki ^c   Ozawa, Hiroki ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b NAGASAKI INTERNATIONAL UNIVERSITY   (Japan)

^c NAGASAKI UNIVERSITY   (Japan)

Author keywords

Duration of untreated psychosis; First episode psychosis; Long term outcome; Predictors; Schizophrenia

Indexed keywords

ADULT; ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; DISEASE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; JAPAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PSYCHIATRIC DIAGNOSIS; PSYCHIATRIC TREATMENT; PSYCHOSIS; REMISSION; SCHIZOPHRENIA; WORLD HEALTH ORGANIZATION;

EID: 16844362408     PISSN: 00016055     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Craig TJ, Bromet EJ, Fenning S et al. Is there an association between duration of untreated psychosis and 24-month clinical outcome in a first admission series? Am J Psychiatry 157: 60-66, 2000
2. Bottlender R, Strauss A, Moller HJ et al. Impact of duration of symptoms prior to first hospitalization on acute outcome of 998 schizophrenic patients. Schizophr Res 44: 145-150, 2000
3. Drake RJ, Haley CJ, Akhtar S et al. Causes and consequences of duration of untreated psychosis in schizophrenia. Br J Psychiatry 177: 511-515, 2000
4. McGorry PD, Edwards J, Mihalpoulos C et al. EPPIC: an evolving system of early detection and optimal management. Schizophr Bull 22: 305-326, 1996
5. Loebel AD, Lieberman JA, Alvir JM et al. Duration of psychosis and outcome in first-episode schizophrenia. Am J Psychiatry 149: 1183-1188, 1992
6. Hasss GL, Garratt LS, Sweeney JA et al. Delay to first antipsychotic medication in schizophrenia: impact on symptomatology and clinical course of illness. J Psychiatr Res 32: 151-159, 1998
7. Scully PJ, Goakley G, Kinsella A et al. Psychological executive (frontal) and general cognitive impairment in relation to duration of initially untreated psychosis in chronic schizophrenia. Psychol Med 27: 1303-1310, 1997
8. Wiersma D, Nienhuis FJ, Slooff CJ et al. Natural course of schizophrenic disorders: a 15-year follow-up of a Dutch incidence cohort. Schizophr Bull 24: 75-85, 1998
9. Waddington JL, Yosseff HA, Kinsella A. Sequential cross sectional and 10-year prospective study of seven negative symptoms in relation to duration of initially untreated psychosis in chronic schizophrenia. Psychol Med 25: 849-857, 1995
10. Kobayashi T. Duration of untreated psychosis and 13-year outcome in first admission schizophrenia. (in Japanese) Jpn J Psychiatr Treat (Seishinka Chiryogaku) 17: 589-596, 2002
11. Yamazawa R, Mizuno M, Nemoto T et al. Duration of untreated psychosis and pathways to psychiatric services in first-episode schizophrenia. Psychiatry and Clinical Neurosciences 58: 76-81, 2004
12. Nakane Y, Ohta Y, Radford MHB. Epidemiological studies of schizophrenia in Japan. Schizophr Bull 18: 75-84, 1992
13. Jablensky A, Sartorius N, Emberg G et al. Schizophrenia: Manifestations, Incidence and Course in Different Cultures: A World Health Organization Ten-country Study. Psychological Medicine Monograph, Suppl 20, Cambridge University Press, Cambridge, 1992
14. World Health Organization. Schizophrenia: A Multinational Study. A Summary of the Initial Evaluation Phase of the International Pilot Study of Schizophrenia. World Health Organization, Geneva, 1975
15. Wing JK, Cooper JE, Sartorius N. Measurement and Classification of Psychiatric Symptoms: An Instruction Manual for the PSE and Catego Program. Cambridge University Press, Cambridge, 1974
16. Katz MM, Lyerly SB. Methods for measuring adjustment and social behavior in the community: 1. Rationale, description, discriminative validity and scale development. Psychol Rep 13: 503-535, 1963
17. Takada K, Yoshitake K, Nakane Y. Nagasaki Schizophrenia Study: Outcome of a 15-year follow-up of an incident cohort. Acta Med Nagasaki 42: 39-44, 1997
18. Harrison G, Hopper K, Craig T et al. Recovery from psychotic illness: a 15- and 25-year international follow-up study. Br J Psychiatry 178: 506-517, 2001
19. Beiser M, Erickson D, Fleming JAE et al. Establishing the onset of psychotic illness. Am J Psychiatry 150: 1349-1354, 1993
20. Larsen TK, McGlashan TH, Moe LC et al. First episode schizophrenia 1: early course parameters. Schizophr Bull 22: 241-256, 1996
21. Browne S, Clarke M, Gervin M et al. Determinants of quality of life at first presentation with Schizophrenia. Br J Psychiatry 176: 173-176, 2000
22. Thomas R, Barnes E, Hutton SB, et al. West London first-episode study of schizophrenia-Clinical correlates of duration of untreated psychosis. Br J Psychiatry 177: 207-211, 2000
23. Malla AK, Norman RM, Manchanda R et al. One year outcome in first episode psychosis: influence of DUP and other predictors. Schizophr Res 54: 231-242, 2002
24. Norman RM, Malla AK. Duration of untreated psychosis: a critical examination of the concept and its importance. Psychol Med 31: 381-400, 2001
25. Bottlender R, Sato T, Markus J et al. The impact of the duration of untreated psychosis prior to first psychiatric admission on the 15-year outcome in schizophrenia. Schizophr Res 62: 37-44, 2003